Meta Pixel

News and Announcements

Kingdom Developments 18-42 months to project completion of Wollongong Central Development | 30%-140% Target Returns

  • Published September 26, 2019 12:00AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

Overview

  • Share price of $65k per share (100 shares in total)
  • 80 apartments + 8 ground floor commercial units (adaptable in line with buyer’s needs)

Key points

  • 2,807sqm B4-zoned site on the doorstep of Wollongong train station.
  • One minute walk onto the Sydney express train platform (Wollongong Central Station).
  • Located in the City Centre zone, between the train station and both Hospitals.
  • Right across the road from Wollongong West TAFE.
  • Located where the bus to Wollongong University leaves from.
  • Enormous exposure, with 65m street frontage and the same frontage onto the train line.

Exit Strategy #1

DA for 80 x Dwellings + 8 x Commercial & Sell

  • Time frame is approximately 12-18 months
  • Target returns of approximately $20k (approx 30%) per share

Exit Strategy #2

DA for 80 x Dwellings + 8 x Commercial & Build

  • Time frame to build completion is approximately 36-42 months
  • Target returns of approximately $91k (140%) per share

Exit Strategy #3

On-sell the Call Option Deed

We also have the ability to on-sell the Call Option Deed to another developer at any time within the 24 months and avoiding paying Stamp Duty.

About Kingdom Developments

Kingdom Developments Australia (KDA) came from our passion for investment vehicles that offer our investors (including us) an exceptional risk vs reward ratio. Our SPV structures allow for investors to join together to co-own and access larger scale property developments than they could individually and in doing so allow for greater efficiencies in economies of scale and stronger returns.

Our vehicle is especially appreciated by investors that have limited time, yet want the lucrative returns of medium to large property developments.

Register Interest

Capital Insights
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship

From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now